Residual TFA and counter-ions on a peptide COA: what the salt form means

Published 5 Nov 2026 · By The QLD Analytical Team

Informational guide for research samples — not medical advice. QLD Analytical arranges independent testing; we do not sell or endorse any product.

Certificates of analysis for research peptides often list a salt form such as trifluoroacetate (TFA) or acetate, and sometimes a residual TFA or residual solvent figure. This guide explains what those lines mean, why the counter-ion is not part of the peptide mass used for identity testing, and how salt form connects to net peptide content.

Why research peptides are sold as salts

Most synthetic peptides carry charged groups: a free N-terminal amine, a free C-terminal acid, and side chains such as lysine, arginine, histidine, aspartic acid or glutamic acid. During purification, those charges are balanced by counter-ions from the chromatography solvents and buffers. The lyophilised powder you receive is therefore a salt of the peptide, not a free-base peptide alone.

The two counter-ions you will see most often on research-peptide certificates of analysis are trifluoroacetate (TFA) and acetate. Less commonly, hydrochloride or formate salts appear. The salt form is a property of the powder, not a chemical modification of the peptide backbone, which is why it does not change the sequence written on the label.

TFA salt vs acetate salt

Trifluoroacetic acid is widely used in reversed-phase HPLC mobile phases for peptide purification. As a result, many crude and purified peptides finish as TFA salts unless the laboratory deliberately exchanges the counter-ion. Acetate salts are produced by an extra ion-exchange or lyophilisation step that replaces TFA with acetic acid.

From a testing perspective, the important differences are:

Mass of the counter-ion. TFA (CF₃COO⁻) is heavier than acetate (CH₃COO⁻). More TFA per peptide molecule means a larger fraction of the powder’s weight is salt rather than peptide.
Stoichiometry. A peptide with several basic residues can bind more than one counter-ion. Labels such as “·xTFA” or “acetate salt” are often approximate; the exact ratio is not always measured.
Downstream use. Some in-vitro workflows prefer acetate because residual TFA can affect certain assays. That preference is a laboratory decision and is separate from identity or purity testing.

Neither form is “more pure” by default. Purity is still measured by HPLC on the peptide-related peaks. Salt form changes how much of the weighed powder is peptide, which is the net peptide content question covered in our guide to HPLC purity vs net peptide content.

Residual TFA and solvent notes on a COA

A COA may list residual TFA, residual solvents, or both, as separate line items from HPLC purity. Residual TFA is the amount of trifluoroacetate still present in the lyophilised material, usually reported as a weight percentage or as “not detected” against a method limit. Residual solvent notes cover process solvents such as acetonitrile, methanol or dichloromethane that may remain after drying.

These results answer a different question from HPLC purity. HPLC purity asks what share of the detected peptide-related peaks is the main peak. Residual TFA and solvents ask how much non-peptide material remains from manufacture. A sample can show high HPLC purity and still carry a measurable TFA load, because TFA is the counter-ion of the intended salt, not an unrelated impurity peak in the peptide chromatogram.

When residual TFA is reported, read it together with the declared salt form. A TFA salt is expected to contain TFA; the figure is then useful as a measured load rather than as a surprise contaminant. An acetate-salt COA that still shows significant residual TFA may indicate incomplete salt exchange, which is worth noting when you interpret net content.

Why the counter-ion is not in the peptide mass

Mass spectrometry measures the peptide ion in solution. Counter-ions dissociate when the sample is dissolved and ionised, so the expected mass on the COA is the mass of the peptide (including any terminal groups or covalent modifications), not the peptide-plus-TFA adduct. That is why a TFA or acetate salt still matches the theoretical peptide mass within the method’s tolerance.

Occasionally a spectrum shows sodium or potassium adducts, but those are ionisation artefacts, not the purification counter-ion. Our guide to reading a mass spectrometry result on a COA covers adducts and charge states in more detail. The practical rule for salt forms is: tell the laboratory the declared salt when you order identity testing, and compare the observed mass to the peptide’s theoretical mass, not to a peptide-plus-TFA total.

How salt form interacts with net peptide content

Net peptide content (NPC) estimates how much of the powder by weight is peptide, after accounting for water, residual solvents and counter-ions. A heavier or more numerous counter-ion lowers NPC for the same HPLC purity. That is why two vials labelled “5 mg” of the same sequence can deliver different amounts of peptide if one is a TFA salt and the other an acetate salt with different residual moisture.

When you read a COA:

Use HPLC purity to judge the peptide-related peak profile.
Use mass spectrometry to confirm identity against the peptide mass.
Use NPC (when reported) to convert a weighed amount of powder into an estimated amount of peptide.
Treat the salt form as the reason NPC is usually well below 100%, even on a high-purity batch.

If NPC is not on the certificate, you cannot infer it from HPLC purity alone. Purity and content are separate measurements, as explained in what a COA should show.

What to check on the COA

Is the salt form stated (TFA, acetate, HCl or other)?
Does the identity result use the peptide mass, not a peptide-plus-salt mass?
If residual TFA or residual solvents are listed, are units and method limits clear?
Is net peptide content reported separately from HPLC purity?
Do the batch number, sample description and salt form match the vial label?

Salt forms and testing through QLD Analytical

QLD Analytical is a testing intermediary. Samples are analysed offsite by Apex Labs Pty Ltd. Our standard panel covers mass spectrometry identity, HPLC purity and net content. When you order, enter the compound name, labelled strength and salt form exactly as printed on the vial so the laboratory can interpret mass and content correctly.

Residual TFA or residual solvent testing is not always part of a standard identity-and-purity panel. If you need those figures, check the available tests at order time or ask before you ship the sample. As with every test we arrange, the result applies only to the sample sent in. Packing and postage details are in our customer guide and FAQ.

FAQ

Does a TFA salt mean the peptide failed purification?

No. TFA is a common counter-ion from HPLC purification. A TFA salt is a normal product form unless the supplier specifically offers an exchanged salt such as acetate.

Why doesn’t residual TFA show up as a purity failure on HPLC?

HPLC purity for peptides usually reports the main peptide peak among peptide-related peaks. The counter-ion is not treated as a peptide impurity peak in that calculation, so residual TFA is reported separately when it is measured at all.

Should the expected mass include TFA?

No. Mass spectrometry sees the peptide ion after the counter-ion dissociates. Compare the observed mass with the theoretical peptide mass, including termini and covalent modifications only.

Can I calculate net peptide content from the salt form alone?

Not reliably. Stoichiometry, residual water and residual solvents all vary. Use a measured net peptide content result when you need to convert powder weight into peptide amount.

Sources

QLD Analytical — Net content testing (how content differs from purity).
QLD Analytical — Mass spectrometry identity testing (salt forms and expected peptide mass).
Unimod protein modifications database — overview of common adduct mass shifts used when interpreting spectra.